# OnCo record nct07145255 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07145255/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07145255", "NCT07145255" ;
  schema:name "Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of ADC in prostate cancer, colorectal cancer and pancreatic ductal adenocarcinoma, run by MBrace Therapeutics, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07145255/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07145255> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2025-09-03" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:companies <https://onco.cc/companies/mbrace-therapeutics/> .